Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.
Moreton, S. G., Szalla, L., Menzies, R. E., & Arena, A. F. | Psychopharmacology | 29 November 2019
Microdosing psychedelics: Motivations, subjective effects and harm reduction.
Lea, T., Amada, N., Jungaberle, H., Schecke, H., & Klein, M. | International Journal of Drug Policy | 25 November 2019
High-dose ketamine infusion for the treatment of posttraumatic stress disorder in combat veterans.
Ross, C., Jain, R., Bonnett, C. J., & Wolfson, P. | Annals of clinical psychiatry: official journal of the American Academy of Clinical Psychiatrists | 1 November 2019
Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.
dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | BMC psychiatry | 28 October 2019
Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
Hutten, N. R., Mason, N. L., Dolder, P. C., & Kuypers, K. P. | Frontiers in psychiatry | 13 September 2019
The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
O’Brien, B., Lijffijt, M., Wells, A., Swann, A. C., & Mathew, S. J. | Pharmaceuticals | 11 September 2019
Hallucinogens and Their Therapeutic Use: A Literature Review
BEGOLA, M. J., & SCHILLERSTROM, J. E. | Journal of Psychiatric Practice | September 2019
Psychedelic drugs-a new era in psychiatry?
Garcia-Romeu, A., & Richards, W. A. | International Review of Psychiatry | September 2019
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Sartori, S. B., & Singewald, N. | Pharmacology & therapeutics | 27 August 2019
MDMA-assisted psychotherapy for posttraumatic stress disorder: A promising novel approach to treatment.
Vermetten, E., & Yehuda, R. | Neuropsychopharmacology | 27 August 2019
Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis.
Bahji, A., Forsyth, A., Groll, D., & Hawken, E. R. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 19 August 2019
Classical psychedelics for the treatment of depression and anxiety: A systematic review.
Muttoni, S., Ardissino, M., & John, C. | Journal of affective disorders | 30 July 2019
Psychedelic microdosing benefits and challenges: an empirical codebook.
Anderson, T., Petranker, R., Christopher, A., Rosenbaum, D., Weissman, C., Dinh-Williams, L. A., ... & Hapke, E. | 10 July 2019 | Harm reduction journal
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Mithoefer, M. C., Feduccia, A. A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., ... & Doblin, R. | Psychopharmacology | 7 May 2019
Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.
Rocha, J. M., Osório, F. L., Crippa, J. A. S., Bouso, J. C., Rossi, G. N., Hallak, J. E., & dos Santos, R. G. | Therapeutic advances in psychopharmacology | 26 April 2019
Dimethyltryptamine: Endogenous Role and Therapeutic Potential.
Rodrigues, A. V., Almeida, F. J., & Vieira-Coelho, M. A. | Journal of psychoactive drugs | 25 April 2019
Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport
Coleman, J. A., Yang, D., Zhao, Z., Wen, P. C., Yoshioka, C., Tajkhorshid, E., & Gouaux, E. | Nature | 24 April 2019
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., ... & Páleníček, T. | Psychopharmacology | 13 April 2019
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.
Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., ... & Páleníček, T. | Psychopharmacology | 13 April 2019
Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA).
Curry, D. W., Berro, L. F., Belkoff, A. R., Sulima, A., Rice, K. C., & Howell, L. L. | Neuropharmacology | 25 March 2019
Embracing Neurodiversity in Psychedelic Science: A Mixed-Methods Inquiry into the MDMA Experiences of Autistic Adults
Danforth, A. L. | Journal of psychoactive drugs | 25 Mar 2019
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy.
Sessa, B., Higbed, L., & Nutt, D. | Frontiers in Psychiatry | 20 March 2019
Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example.
Wagner, A. C., Mithoefer, M. C., Mithoefer, A. T., & Monson, C. M. | Journal of psychoactive drugs | 19 March 2019
Chronic, Intermittent Microdoses of the Psychedelic N, N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents.
Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. | ACS chemical neuroscience | 4 March 2019
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. | ACS chemical neuroscience | 4 March 2019